ArticleJournal of the Association for Research in Otolaryngology : JARO2026

Single Intratympanic Injection of Proprietary Brain-Derived Neurotrophic Factor (OTO-413) in Subjects with Speech-in-Noise Hearing Impairment: a Randomized, Dose Escalating, Double-Blind, Placebo-Controlled Phase 1/2 Study.

Alan C Foster et al.PubMed ↗Publisher ↗

No numbers read from the abstract.